Type 2 Diabetes and clinical inertia

East MidlandsMetabolic and Endocrine
Published Date: 1 Mar 2015

Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care

Who needs to know?

Healthcare providers working in UK primary care.

What have we found?

Some willingness to accept a degree of responsibility for clinical inertia in the management of type 2 diabetes, but participants sought to lessen their own sense of accountability by highlighting patient-level barriers such as comorbidities and human fallibility, and also system-level barriers, particularly time constraints. In some cases, participants had inaccurate perceptions about levels of target achievement in their primary care centres, as indicated by routine (QOF) data.

Download